Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Fujifilm aims to...

    Fujifilm aims to double revenue from medical systems in India

    Written by supriya kashyap kashyap Published On 2017-06-26T11:29:04+05:30  |  Updated On 26 Jun 2017 11:29 AM IST
    Fujifilm aims to double revenue from medical systems in India

    New Delhi : Japanese photography and imaging company Fujifilm is confident of doubling revenues from its medical systems business to over Rs 1,000 crore, buoyed by opportunities in tier II and III cities.


    Fujifilm, a leader in the diagnostic imaging space, is also actively engaged in various Public Private Partnership projects floated by government agencies to provide its products and services.


    "We are growing at 15 to 20 per cent in the (medical systems) segment. My hope is that we would grow more than double in the next five years," Fujifilm India Managing Director Yasunobu Nishiyama told .


    Medical health care products account for about 50 per cent of the company's Rs 1,000 crore turnover in India, a nascent but growing market for the company, accounting for about 2 per cent of its global business.


    Its other businesses in the country include photo imaging (30 per cent), graphics systems (15 per cent) and industrial products and others (55 per cent).


    Nishiyama said Fujifilm is keen on exploring opportunities in the existing healthcare centres in the country, where the old conventional analogue X-ray machines are being replaced with digital ones.


    "We want to promote better medical equipment systems in tier II and III cities. The world is going digital and in India too, analogue machines are being changed to digital X- ray," he added.


    He further said: "Now the demand is very huge, specially in PPP and private hospitals. So we are collaborating with them."


    Fujifilm addresses product categories like computed radiography, digital radiography, digital mammography, dry imager, film and screen, endoscopy and point-of-care testing products/clinical chemistry system in India.


    The Japanese firm has also started collaborating with the local players which are integrating its system and software in their mobile X-ray units.

    AIIMSFujifilmJapanese firmMedical health caremedical systempublic private partnershipYasunobu Nishiyama
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok